{"id":5,"date":"2019-01-18T18:41:32","date_gmt":"2019-01-18T23:41:32","guid":{"rendered":"https:\/\/sites.bu.edu\/joneslab\/jones-lab\/"},"modified":"2026-08-05T07:12:22","modified_gmt":"2026-08-05T11:12:22","slug":"jones-lab","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/joneslab\/","title":{"rendered":""},"content":{"rendered":"<div style=\"background-color: #000000;\">\n<p>  <!-- QUESTION 1 --><\/p>\n<div style=\"display: flex; align-items: center; min-height: 60vh; padding: 40px 40px; gap: 40px; background-color: #000000;\">\n<div style=\"flex: 1;\">\n<h2 style=\"font-size: 40px; font-weight: 300; line-height: 1.3; margin: 0; color: #ffffff;\">\n        How can we promote T cell infiltration into metastatic breast cancer?<br \/>\n      <\/h2>\n<\/p><\/div>\n<div style=\"flex: 1;\">\n      <img src=\"\/joneslab\/files\/2026\/08\/Screenshot-2026-08-05-at-6.49.53\u202fAM.png\" alt=\"Tumor vasculature\" style=\"width: 100%; height: auto; border-radius: 8px; object-fit: cover;\">\n    <\/div>\n<\/p><\/div>\n<p>  <!-- QUESTION 2 --><\/p>\n<div style=\"display: flex; align-items: center; min-height: 60vh; padding: 40px 40px; gap: 40px; flex-direction: row-reverse; background-color: #000000;\">\n<div style=\"flex: 1;\">\n<h2 style=\"font-size: 40px; font-weight: 300; line-height: 1.3; margin: 0; color: #ffffff;\">\n        Can targeting cancer-associated fibroblasts unlock immunotherapy responses in breast cancer?<br \/>\n      <\/h2>\n<\/p><\/div>\n<div style=\"flex: 1;\">\n      <img src=\"\/joneslab\/files\/2026\/08\/Screenshot-2026-08-05-at-7.11.17\u202fAM.png\" alt=\"Cancer-associated fibroblasts\" style=\"width: 100%; height: auto; border-radius: 8px; object-fit: cover;\">\n    <\/div>\n<\/p><\/div>\n<p>  <!-- QUESTION 3 --><\/p>\n<div style=\"display: flex; align-items: center; min-height: 60vh; padding: 40px 40px; gap: 40px; background-color: #000000;\">\n<div style=\"flex: 1;\">\n<h2 style=\"font-size: 40px; font-weight: 300; line-height: 1.3; margin: 0; color: #ffffff;\">\n        How does bacterial infection damage lymphatic vessels and perpetuate chronic disease?<br \/>\n      <\/h2>\n<\/p><\/div>\n<div style=\"flex: 1;\">\n      <img src=\"\/joneslab\/files\/2026\/08\/saPicture1.png\" alt=\"Lymphatic vessel damage\" style=\"width: 100%; height: auto; border-radius: 8px; object-fit: cover;\">\n    <\/div>\n<\/p><\/div>\n<\/div>\n<style>\n  @media (max-width: 768px) {\n    div[style*=\"display: flex\"] {\n      flex-direction: column !important;\n    }\n    h2 {\n      font-size: 28px !important;\n    }\n  }\n<\/style>\n","protected":false},"excerpt":{"rendered":"<p>How can we promote T cell infiltration into metastatic breast cancer? Can targeting cancer-associated fibroblasts unlock immunotherapy responses in breast cancer? How does bacterial infection damage lymphatic vessels and perpetuate chronic disease?<\/p>\n","protected":false},"author":15827,"featured_media":0,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/pages\/5"}],"collection":[{"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/users\/15827"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/comments?post=5"}],"version-history":[{"count":50,"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/pages\/5\/revisions"}],"predecessor-version":[{"id":502,"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/pages\/5\/revisions\/502"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/joneslab\/wp-json\/wp\/v2\/media?parent=5"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}